Journal of Psychopharmacology Issues Research Articles in February 2022 Edition
February 17, 2022
February 17, 2022
LONDON, England, Feb. 17 -- The Journal of Psychopharmacology, a peer-reviewed journal that says it features preclinical and clinical aspects of psychopharmacology, published research articles on the following topics in its February 2022 edition:
Review:
* Modulation of microglial activation by antidepressants
Original Papers:
* Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up< . . .
Review:
* Modulation of microglial activation by antidepressants
Original Papers:
* Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up< . . .